Home
>
National Drug Code (NDC)
>
Privigen
Privigen - 44206-436-05 - (Human Immunoglobulin G)
Drug Information of Privigen
| Product NDC: | 44206-436 |
| Proprietary Name: | Privigen |
| Non Proprietary Name: | Human Immunoglobulin G |
| Active Ingredient(s): | 5 g/50mL & nbsp; Human Immunoglobulin G |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Privigen
| Product NDC: | 44206-436 |
| Labeler Name: | CSL Behring AG |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125201 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090120 |
Package Information of Privigen
| Package NDC: | 44206-436-05 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (44206-436-05) > 50 mL in 1 VIAL, GLASS (44206-436-90) |
NDC Information of Privigen
| NDC Code | 44206-436-05 |
| Proprietary Name | Privigen |
| Package Description | 1 VIAL, GLASS in 1 CARTON (44206-436-05) > 50 mL in 1 VIAL, GLASS (44206-436-90) |
| Product NDC | 44206-436 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Human Immunoglobulin G |
| Dosage Form Name | LIQUID |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090120 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring AG |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Strength Number | 5 |
| Strength Unit | g/50mL |
| Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
